Andre Aung, MD
Ophthalmology · Encinitas, CANPI 1750802880
Payments from drug & device makers
Across 122 payments — averaging $59.21 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Bausch & Lomb Americas Inc.$2K
- Amgen$1K
- Alcon$815
- Sight Sciences, Inc.$633
- NEW World Medical,inc.$423
- Regeneron Healthcare Solutions, Inc.$381
- plus $1K from 14 others
What the payments were for
- Travel & lodging$1,30018%
- Food & beverage$5,91582%
- Education$80%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Bausch & Lomb Americas Inc. | 33 | $2,338 |
| Amgen(2 entities) | 27 | $1,157 |
| Alcon | 10 | $815 |
| Sight Sciences, Inc. | 5 | $633 |
| NEW World Medical,inc. | 2 | $423 |
| Regeneron Healthcare Solutions, Inc. | 11 | $381 |
| Glaukos Corporation | 2 | $359 |
| Carl Zeiss Meditec USA, Inc. | 1 | $157 |
| Novartis | 6 | $148 |
| Rxsight Inc | 1 | $137 |
| Bausch & Lomb, A Division Of Bausch Health US, LLC | 6 | $128 |
| Tarsus Pharmaceuticals, Inc. | 4 | $119 |
| Apellis Pharmaceuticals, Inc. | 1 | $98 |
| AbbVie(2 entities) | 4 | $96 |
| AstraZeneca | 3 | $84 |
| Johnson & Johnson Surgical Vision, Inc. | 2 | $45 |
| Astellas Pharma US Inc | 1 | $32 |
| Ivantis, Inc | 1 | $28 |
| Oyster Point Pharma, Inc. | 1 | $23 |
| Mallinckrodt Hospital Products Inc. | 1 | $22 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- enVista MX60 IOL$1,551
- STELLARIS ELITE$1,293
- Crystalens Accommodating IOL (AT-52AO)$1,293
- Trulign IOL$1,293
- Akreos AO IOL$1,293
- TEPEZZA$694
- OMNI(R) SURGICAL SYSTEM (US)$547
- Kahook Dual Blade$245
- Streamline Surgical System$245
- Ahmed Glaucoma Valve$245
- iDose$222
- ARGOS$171
- VERACITY SURGICAL$157
- iStent Trabecular Micro-Bypass System Model iS3$138
- RXSIGHT CONTACT LENS$137
- RXSIGHT INJECTOR CARTRIDGE$137
- RXSIGHT INJECTOR HANDPIECE$137
- RXSIGHT LIGHT DELIVERY DEVICE (LDD)$137
- LIGHT ADJUSTABLE LENS (LAL)$137
- IC-8 Apthera IOL$131
How this compares
$7,223 in reported general payments places this provider in the 80th percentile of 2,513 ophthalmology providers in California.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Cyclosporine | 21 | $5,780 |
| Prednisolone Acetate | 89 | $3,266 |
| Latanoprost | 208 | $1,903 |
| Brimonidine Tartrate | 14 | $1,780 |
| MoxifloxacinMoxifloxacin Hcl | 61 | $1,238 |
| Ketorolac Tromethamine | 62 | $798 |
| Dorzolamide-TimololDorzolamide Hcl/Timolol Maleat | 31 | $463 |
| Neomycin-Polymyxin-DexamethNeomycin/Polymyxin B/Dexametha | 14 | $147 |
| Prednisone | 16 | $78 |
Paid to pharmacies, not to this prescriber.
Other ophthalmology in Encinitas
- Nisha AcharyaSan Francisco$33M
- David WirtaNewport Beach$18.4M
- Michael IpPasadena$10.2M
- Raymond DouglasBeverly Hills$9.7M
- Sherif El HaraziGlendale$9.2M
- Daniel SchwartzSan Francisco$8M
- Nikolas Londonla Jolla$6.1M
- Michael BerlinWest Hollywood$5.7M
- Steven JacobsonLos Angeles$4.7M
- Peter WinArcadia$4.2M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.